-1%

est. 2Y upside i

Healthcare

Building the safety net of the future

Rank

#2322

Sector

Digital Health

Est. Liquidity

~4Y

Data Quality

Data: Low

Given the missing valuation data and reliance on assumptions, the expected equity upside is slightly negative (-0.9%) in the base scenario, with significant downside risk from preference stack overhang.

Last updated: July 19, 2026

Bull (20%)+75%

Revenue grows to $19.5M and exit multiple holds at 5x due to IPO window or category leadership, yielding ~$97.5M exit. After 20% dilution, upside 75%.

Base (55%)+17%

Revenue reaches $19.5M and multiple converges to 3.5x, exit ~$68.25M. Dilution of 20% reduces upside to 16.5%.

Bear (25%)-100%

Revenue disappoints or multiple compresses to 2x, exit $39M below $39.9M preference stack, common stock worthless (-100%).

Est. time to liquidity~4.0 years

Preference Stack Risk

severe

Funding Intensity

0%

Total funding of $39.9M is 79.8% of estimated $50M valuation, meaning preferred shareholders hold large liquidation preference.

Dilution Risk

high

With $39.9M raised and not profitable, additional funding within 24 months is likely, diluting common by ~20%.

Secondary Liquidity

none

No secondary market transactions reported.

Other 23 roles

View all 23 open roles at Pair Team

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Pair Team's data — designed to show you've done your homework.

  • 1

    How does Pair Team's AI differentiate from existing care coordination platforms?

  • 2

    What is the unit economics per patient and how does it scale with increased enrollment?

  • 3

    Given the company's reliance on government contracts, how does the equity plan accommodate exit scenarios like acquisition vs IPO?

Community

Valuation Sentiment

Our model estimates -1% upside. What do you think?

Anonymous. Do not share material non-public information.


Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.